What Luspatercept does

Luspatercept (Luspatercept) is an innovative drug used to treat specific anemia diseases. Its main function is to improve the process of red blood cell production and maturation. This drug represents an important advance in the medical field for the treatment of blood disorders and provides a new treatment option for patients suffering from these diseases.

The mechanism of action of Rotercept is based on its interaction with activatedTGF-β superfamily receptors. Receptors from this family regulate erythropoiesis in vivo and the development of immature red blood cells in the bone marrow. When these receptors are activated, they block the normal production of red blood cells, causing symptoms of anemia. Rotexip works by binding to these receptors and changing their signaling pathways, thereby increasing the development and maturation of immature red blood cells and improving the quantity and quality of red blood cells. This process helps improve patients' anemia symptoms and enhances the ability to deliver oxygen to all parts of the body.

Rotacept has been approved to treat two major blood disorders:

1.Aplastic anemia that is highly dependent on blood transfusion (β-thalassemia): This is a hereditary anemia disease in which the number of red blood cells is severely reduced and patients usually require frequent blood transfusions to maintain life. The use of Rotercept can reduce dependence on blood transfusions and improve patients' quality of life.

2.Myelodysplastic syndromes (MDS): MDS are a group of bone marrow disorders that often lead to anemia and other blood problems. Treatment with Rotercept can improve the number and quality of patients' red blood cells and reduce symptoms of anemia.

Although Rotacept is very effective at improving symptoms of anemia, it may be associated with some side effects, including headache, high blood pressure, nausea, fatigue, and diarrhea. Serious adverse reactions are rare but may include allergic reactions, pulmonary thromboembolism, and bleeding.

Rotexip is already on the market in China and has been included in medical insurance. Patients can purchase it domestically. For specific prices, please consult the local hospital pharmacy. There are only original drugs for Rotesip abroad, mainly European ones, with a price of more than 10,000 yuan.